MCUJF
Price
$0.94
Change
+$0.06 (+6.82%)
Updated
Jul 31 closing price
Capitalization
8.73M
PAIOF
Price
$0.01
Change
-$0.01 (-50.00%)
Updated
May 12 closing price
Capitalization
81.1K
Interact to see
Advertisement

MCUJF vs PAIOF

Header iconMCUJF vs PAIOF Comparison
Open Charts MCUJF vs PAIOFBanner chart's image
Medicure
Price$0.94
Change+$0.06 (+6.82%)
Volume$300
Capitalization8.73M
Paion AG
Price$0.01
Change-$0.01 (-50.00%)
Volume$100
Capitalization81.1K
MCUJF vs PAIOF Comparison Chart in %
Loading...
MCUJF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PAIOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MCUJF vs. PAIOF commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MCUJF is a Buy and PAIOF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 17, 2025
Stock price -- (MCUJF: $0.94 vs. PAIOF: $0.01)
Brand notoriety: MCUJF and PAIOF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: MCUJF: 33% vs. PAIOF: 100%
Market capitalization -- MCUJF: $8.73M vs. PAIOF: $81.1K
MCUJF [@Pharmaceuticals: Generic] is valued at $8.73M. PAIOF’s [@Pharmaceuticals: Generic] market capitalization is $81.1K. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MCUJF’s FA Score shows that 1 FA rating(s) are green whilePAIOF’s FA Score has 0 green FA rating(s).

  • MCUJF’s FA Score: 1 green, 4 red.
  • PAIOF’s FA Score: 0 green, 5 red.
According to our system of comparison, MCUJF is a better buy in the long-term than PAIOF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MCUJF’s TA Score shows that 4 TA indicator(s) are bullish while PAIOF’s TA Score has 2 bullish TA indicator(s).

  • MCUJF’s TA Score: 4 bullish, 3 bearish.
  • PAIOF’s TA Score: 2 bullish, 0 bearish.
According to our system of comparison, both MCUJF and PAIOF are a good buy in the short-term.

Price Growth

MCUJF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while PAIOF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +6.26%. For the same industry, the average monthly price growth was +68.76%, and the average quarterly price growth was +80.82%.

Industries' Descriptions

@Pharmaceuticals: Generic (+6.26% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MCUJF($8.73M) has a higher market cap than PAIOF($81.1K). MCUJF YTD gains are higher at: 52.129 vs. PAIOF (-50.000).
MCUJFPAIOFMCUJF / PAIOF
Capitalization8.73M81.1K10,760%
EBITDA951KN/A-
Gain YTD52.129-50.000-104%
P/E Ratio11.51N/A-
Revenue21.7MN/A-
Total Cash7.22MN/A-
Total Debt876KN/A-
FUNDAMENTALS RATINGS
MCUJF vs PAIOF: Fundamental Ratings
MCUJF
PAIOF
OUTLOOK RATING
1..100
442
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
61
Fair valued
PROFIT vs RISK RATING
1..100
90100
SMR RATING
1..100
9494
PRICE GROWTH RATING
1..100
3886
P/E GROWTH RATING
1..100
26100
SEASONALITY SCORE
1..100
5025

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PAIOF's Valuation (61) in the null industry is in the same range as MCUJF (63). This means that PAIOF’s stock grew similarly to MCUJF’s over the last 12 months.

MCUJF's Profit vs Risk Rating (90) in the null industry is in the same range as PAIOF (100). This means that MCUJF’s stock grew similarly to PAIOF’s over the last 12 months.

MCUJF's SMR Rating (94) in the null industry is in the same range as PAIOF (94). This means that MCUJF’s stock grew similarly to PAIOF’s over the last 12 months.

MCUJF's Price Growth Rating (38) in the null industry is somewhat better than the same rating for PAIOF (86). This means that MCUJF’s stock grew somewhat faster than PAIOF’s over the last 12 months.

MCUJF's P/E Growth Rating (26) in the null industry is significantly better than the same rating for PAIOF (100). This means that MCUJF’s stock grew significantly faster than PAIOF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MCUJFPAIOF
RSI
ODDS (%)
Bearish Trend 3 days ago
79%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
79%
N/A
Momentum
ODDS (%)
Bullish Trend 3 days ago
74%
N/A
MACD
ODDS (%)
Bullish Trend 3 days ago
67%
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
61%
Bullish Trend 3 days ago
22%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
62%
Bullish Trend 3 days ago
18%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
74%
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
81%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
MCUJF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PAIOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AGL1.110.05
+4.72%
agilon health
JXG1.000.03
+2.67%
JX Luxventure Group Inc
GLPG32.470.68
+2.14%
Galapagos NV
RBC394.75-7.17
-1.78%
RBC Bearings
ELUT2.02-0.13
-6.05%
Elutia

MCUJF and

Correlation & Price change

A.I.dvisor tells us that MCUJF and PAIOF have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MCUJF and PAIOF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MCUJF
1D Price
Change %
MCUJF100%
N/A
PAIOF - MCUJF
21%
Poorly correlated
N/A
LVRLF - MCUJF
18%
Poorly correlated
+19.28%
MVMDF - MCUJF
11%
Poorly correlated
-22.01%
MGWFF - MCUJF
9%
Poorly correlated
-34.87%
JUSHF - MCUJF
7%
Poorly correlated
-10.65%
More

PAIOF and

Correlation & Price change

A.I.dvisor indicates that over the last year, PAIOF has been loosely correlated with ASRT. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if PAIOF jumps, then ASRT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PAIOF
1D Price
Change %
PAIOF100%
N/A
ASRT - PAIOF
34%
Loosely correlated
-0.64%
RGEDF - PAIOF
33%
Loosely correlated
N/A
ETON - PAIOF
22%
Poorly correlated
+2.04%
CPIX - PAIOF
21%
Poorly correlated
+4.68%
MCUJF - PAIOF
21%
Poorly correlated
N/A
More